These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34433636)

  • 1. Quantification of microRNA editing using two-tailed RT-qPCR for improved biomarker discovery.
    Voss G; Edsjö A; Bjartell A; Ceder Y
    RNA; 2021 Nov; 27(11):1412-1424. PubMed ID: 34433636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-Tailed RT-qPCR for the Quantification of A-to-I-Edited microRNA Isoforms.
    Voss G; Ceder Y
    Curr Protoc; 2023 Jan; 3(1):e645. PubMed ID: 36688607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine-to-Inosine RNA Editing Enzyme ADAR and microRNAs.
    Yuting K; Ding D; Iizasa H
    Methods Mol Biol; 2021; 2181():83-95. PubMed ID: 32729076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional consequences of A-to-I editing of miR-379 in prostate cancer cells.
    Voss G; Cassidy JR; Ceder Y
    Sci Rep; 2023 Oct; 13(1):16602. PubMed ID: 37789115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
    Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
    Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells.
    Choudhury Y; Tay FC; Lam DH; Sandanaraj E; Tang C; Ang BT; Wang S
    J Clin Invest; 2012 Nov; 122(11):4059-76. PubMed ID: 23093778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.
    Nakano M; Fukami T; Gotoh S; Nakajima M
    J Biol Chem; 2017 Mar; 292(12):4873-4884. PubMed ID: 28188287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer.
    Bhagirath D; Yang TL; Bucay N; Sekhon K; Majid S; Shahryari V; Dahiya R; Tanaka Y; Saini S
    Cancer Res; 2018 Apr; 78(7):1833-1844. PubMed ID: 29437039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine-to-Inosine Editing of MicroRNA-487b Alters Target Gene Selection After Ischemia and Promotes Neovascularization.
    van der Kwast RVCT; van Ingen E; Parma L; Peters HAB; Quax PHA; Nossent AY
    Circ Res; 2018 Feb; 122(3):444-456. PubMed ID: 29284691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine-to-Inosine Editing of Vasoactive MicroRNAs Alters Their Targetome and Function in Ischemia.
    van der Kwast RVCT; Parma L; van der Bent ML; van Ingen E; Baganha F; Peters HAB; Goossens EAC; Simons KH; Palmen M; de Vries MR; Quax PHA; Nossent AY
    Mol Ther Nucleic Acids; 2020 Sep; 21():932-953. PubMed ID: 32814251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA detection in prostate tumors by quantitative real-time PCR (qPCR).
    Gordanpour A; Nam RK; Sugar L; Bacopulos S; Seth A
    J Vis Exp; 2012 May; (63):e3874. PubMed ID: 22643910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-96-5p, miR-134-5p, miR-181b-5p and miR-200b-3p heterogenous expression in sites of prostate cancer versus benign prostate hyperplasia-archival samples study.
    Pełka K; Klicka K; Grzywa TM; Gondek A; Marczewska JM; Garbicz F; Szczepaniak K; Paskal W; Włodarski PK
    Histochem Cell Biol; 2021 Mar; 155(3):423-433. PubMed ID: 33331954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence.
    Spahn M; Kneitz S; Scholz CJ; Stenger N; Rüdiger T; Ströbel P; Riedmiller H; Kneitz B
    Int J Cancer; 2010 Jul; 127(2):394-403. PubMed ID: 19585579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered editing level of microRNAs is a potential biomarker in lung adenocarcinoma.
    Maemura K; Watanabe K; Ando T; Hiyama N; Sakatani T; Amano Y; Kage H; Nakajima J; Yatomi Y; Nagase T; Takai D
    Cancer Sci; 2018 Oct; 109(10):3326-3335. PubMed ID: 30022565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model.
    Lin Y; Chen F; Shen L; Tang X; Du C; Sun Z; Ding H; Chen J; Shen B
    J Transl Med; 2018 May; 16(1):134. PubMed ID: 29784056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adaptive potential of RNA editing-mediated miRNA-retargeting in cancer.
    Tassinari V; Cesarini V; Silvestris DA; Gallo A
    Biochim Biophys Acta Gene Regul Mech; 2019 Mar; 1862(3):291-300. PubMed ID: 30605729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
    Ghorbanmehr N; Gharbi S; Korsching E; Tavallaei M; Einollahi B; Mowla SJ
    Prostate; 2019 Jan; 79(1):88-95. PubMed ID: 30194772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-21 in peripheral blood mononuclear cells as a novel biomarker in the diagnosis and prognosis of prostate cancer.
    Yang B; Liu Z; Ning H; Zhang K; Pan D; Ding K; Huang W; Kang XL; Wang Y; Chen X
    Cancer Biomark; 2016 Jul; 17(2):223-30. PubMed ID: 27434290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic value of serum miR-15a and miR-16-1 expression among egyptian patients with prostate cancer.
    Zidan HE; Abdul-Maksoud RS; Elsayed WSH; Desoky EAM
    IUBMB Life; 2018 May; 70(5):437-444. PubMed ID: 29522280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of miR-20a expression in prostate cancer tissue.
    Pesta M; Klecka J; Kulda V; Topolcan O; Hora M; Eret V; Ludvikova M; Babjuk M; Novak K; Stolz J; Holubec L
    Anticancer Res; 2010 Sep; 30(9):3579-83. PubMed ID: 20944140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.